Congratulations! BiOptic has won“The 25th Rising Star Award”
2022-11-17
BiOptic has won“The 25th Rising Star Award”, which is awarded by the Ministry of Economic Affairs. We are so honored that BiOptic could stands out from all Bio-industry companies in Taiwan and be the only Bio-company of the 16 winning companies from various industries. The award ceremony was held on the 16th of November, and Dr. Ming-Jhy Hsu, Chief R&D Director, representing BiOptic to receive this award.
Welcome to our booth. This time, you will see the whole Qsep1 series. The world's smallest capillary electrophoresis instrument, including Qsep1-Lite, the entry-level model, Qsep1, the standard model, and Qsep1-Plus, the advanced version.
BiOptic hits a new high in revenue in the first 10-month of 2022
2022-11-11
The world's largest medical tradeshow, MEDICA, in Dusseldorf Germany will be held from November 14th to 17th. BiOptic will participate in the exhibition for the first time after the COVID-19 epidemic. Chairman Eric Tsai said that the company has actively expanded the European market in recent years and the penetration rate continues to increase.
Direct SARS-CoV-2 Detection System Utilizing Simple-to-Use Capillary Gel Electrophoresis
2022-11-08
We present a Direct SARS-CoV-2 Detection System that achieves sample-to-results in less than two hours in three simple steps. The Detection System includes Direct one-step Reverse Transcription PCR (RT-PCR) reagents (Qexp-MDx kit), a portable thermal cycler (Qamp-mini) with a pre-programmed chip, and a simple-to-use Capillary Gel Electrophoresis system (Qsep Series Bio-Fragment Analyzer) with high fluorescence detection sensitivity to solve the problems associated with traditional real-time PCR (qPCR) systems which produce inaccurate test results with high false negative and false positive rates. The proposed simple-to-use detection platform can provide high detection sensitivity (identify less than 20 copies), fast results (less than 120 minutes), and cost-effective results which should be suitable for decentralized testing applications of COVID-19.
BiOptic has signed memorandum of cooperation with the school of medicine, Chang Gung University
2022-10-28
The school of medicine in Chang Gung University and BiOptic signed a memorandum of cooperation on the morning of October 24th. Starting from the summer vacation of 2023, master and doctoral students of the school's biotechnology industry program can enter the company for a 6-week summer internship program
BiOptic Inc. was invited to participate in the 2022 Taiwan Innovation and Technology Expo this year and will be grandly exhibited at the World Trade Center Hall 1-Innovation Navigation Hall from 2022/10/13-10/15.
